bpc-157 human clinical trial tendon healing randomized Frontiers Stable gastric pentadecapeptide BPC 157
Description
,
Bodybuilding forums offer fragmented anecdotes without systematic documentation
Fewer systemic side-effects compared to hGH Because AOD 9604 does not significantly elevate IGF-1 or impair glucose/insulin regulation (in trials), it may carry lower risk of some growth hormone-associated adverse effects
They disrupt fundamental cellular processes, including energy production, insulin signaling, glucose metabolism, and mitochondrial function, at times contributing to cognitive decline, fatigue, reduced ability to fight infections, and increased chronic disease risk
